Pharmaceutical/Biotech

AMR Research expects shared services organizations and outsourcing delivery models to be a crucial vehicle for reducing sourcing and procurement overhead expenses. This will be enabled by a labor arbitrage, centralization of resources, tighter efficiencies in managed spend, improved process acumen and access to new technologies. These technologies, however, will see a shift from traditional license approaches to a more economical, integrated SaaS approach.

Resiliency in Supply Chain Is Key to Long-Term Business Continuity

February 24, 2009

Viktoriya Sadlovska, research analyst, Aberdeen Group

To improve supply chain resiliency, companies need to include risk considerations in their supply chain network design efforts, sales and operations planning, and inventory planning; on the execution side, they need to improve logistics and transportation management, secure alternative supply chain partners, and ensure proactive alerting process and response management for disruptions.

Protecting Your Supply Chain Against Financial Vulnerability

February 20, 2009

Beth Enslow, senior vice president, supply chain risk management, Marsh Inc.

The global credit crunch is jeopardizing the financial health of our supply chains. In 2009, companies should reassess suppliers' financial stability and implement processes to spot operational red flags that are early warning signals of financial stress.

Pharmaceutical/Biotech

The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.